May 18, 2023 01:40 PM EDTUpdated May 19, 05:52 PM

AbbVie tackles ‘gutsy’ conversation in social media series for IBD sufferers

Beth Snyder Bulik

Senior Editor

AbbVie wants to remind people about the importance of honest discussions in inflammatory bowel disease (IBD) with the kickoff of a new YouTube conversation series …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

AbbVie tackles ‘gutsy’ conversation in social media series for IBD sufferers

Beth Snyder Bulik

Senior Editor

Sign up to read this article for free.

Executive Director, Marketing

Celldex Therapeutics

Hampton, NJ, USA

Bristol Myers' schizophrenia drug fails Phase 3 trial for adjunctive treatment

China’s biotech market is staging a comeback that US biotech can only wish for

Ascletis posts puzzling Phase 1 update on obesity pill

Genentech vet launches ADC startup with $20M

With aims to become a 'generational biotech,' Zealand Pharma hires Lilly veteran as science chief

ADSTILADRIN® (nadofaragene firadenovec-vncg) – A Growing Body of Clinical Data and Real-World Evidence

Ab­b­Vie tack­les ‘gut­sy’ con­ver­sa­tion in so­cial me­dia se­ries for IBD suf­fer­ers

Senior Editor

Sign up to read this article for free.

Celldex Therapeutics

Hampton, NJ, USA

AbbVie tackles ‘gutsy’ conversation in social media series for IBD sufferers